Vimarsana
Biggest News Aggregation in the World

Page 6 - Tim Bertram News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Tim Bertram. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Tim Bertram Today - Breaking & Trending Today

Revolutionary Chronic Kidney Disease Therapeutics Company - Vimarsana News

Revolutionary Chronic Kidney Disease Therapeutics Company

ProKidney Class A ordinary shares to begin trading on Nasdaq under the ticker symbol “PROK” on July 12, 2022 ProKidney receives total gross proceeds of...

Farmers, tornado victims help others recover from disaster - Vimarsana News

Farmers, tornado victims help others recover from disaster

Shared traumatic experiences can bring people closer together, even if they are normally miles apart. That was the case recently in the Muhlenberg County community of Bremen as Northern Kentucky

Farmers, Tornado Victims Help Others Recover - Vimarsana News

Farmers, Tornado Victims Help Others Recover

March 2, 2012, marks the date of one of the worst tornadic events on record in almost 40 years across Kentucky. Tornadoes blanketed the state on that fateful day and that's why farmers who were affected came to the aid of other farmers torn apart by twisters that ripped through Kentucky this past December. Farmers felt compelled to "pay it forward" to help those in need in Western Kentucky.

Source: uky.edu
Farmers, tornado victims help others recover from disaster - Vimarsana News

Farmers, tornado victims help others recover from disaster

A group of Campbell County producers traveled to Muhlenberg County in Kentucky to help farmers recover and repair the damages from the December 10 tornados.

Regenerative med biotech ProKidney inks $825M merger to back CKD cell therapy - Vimarsana News

Regenerative med biotech ProKidney inks $825M merger to back CKD cell therapy

ProKidney is going public in a SPAC merger that infuses the biotech with $825 million for Phase 3 tests and manufacturing of its autologous cell therapy for chronic kidney disease. More than slowing the decline in organ function, ProKidney says its cell therapy offers the potential to reverse injury caused by the condition.